RFL - NYSE
Rafael Holdings, Inc.
$1.39
+7.0%Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
At a Glance
Live SnapshotRafael Holdings, Inc. Street Expectations Map
No Target Data
No analyst price targets available for rfl.
Rafael Holdings, Inc. Forward Estimates of Revenue
Forward Growth Analysis
Analyst skepticism evident—carefully evaluate risks before investment decisions.
Rafael Holdings, Inc. Forward Estimates of Net Income
Forward Growth Analysis
Analyst skepticism evident—carefully evaluate risks before investment decisions.
Rafael Holdings, Inc. Forward Estimates of EPS
Forward Growth Analysis
Analyst skepticism evident—carefully evaluate risks before investment decisions.
Rafael Holdings, Inc. Forward Estimates of EBIT
Forward Growth Analysis
Analyst skepticism evident—carefully evaluate risks before investment decisions.
Rafael Holdings, Inc. Forward Estimates of EBITDA
Forward Growth Analysis
Analyst skepticism evident—carefully evaluate risks before investment decisions.
Rafael Holdings, Inc. Forward Estimates of SG&A Expense
Forward Growth Analysis
Analyst skepticism evident—carefully evaluate risks before investment decisions.
Rafael Holdings, Inc. Insider Positioning
During the last 12 months, insiders have purchased $15.74M worth of RFL shares, with no selling activity reported.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
12.3M
15.74M
0
0.00
+15.7M
+$15.74M
Top Buyers
Jonas Howard S
Director, 10 Percent Owner, Officer: Exec Chairman, Ceo & President
$15.74M
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $15.74M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Insider Participation
1 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Unanimous insider buying: Zero selling combined with active buying is rare and typically very bullish. Insiders appear to see significant upside with limited downside risk.
Related Guides
Continue your RFL research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.